嵌合抗原受体
细胞毒性
白细胞介素21
癌症研究
NK-92
CD19
白细胞介素12
细胞毒性T细胞
淋巴瘤
抗原
免疫学
生物
免疫疗法
体外
免疫系统
CD8型
生物化学
作者
Qian Liu,Yingxi Xu,Junli Mou,Kejing Tang,Xuehang Fu,Yihui Li,Yanyan Xing,Qing Rao,Haiyan Xing,Tian Zheng,Min Wang,Jianxiang Wang
出处
期刊:Cytotherapy
[Elsevier BV]
日期:2020-08-01
卷期号:22 (10): 552-562
被引量:45
标识
DOI:10.1016/j.jcyt.2020.06.003
摘要
Background aims Anti-CD19 chimeric antigen receptor (CAR)-modified T cells have shown dramatic cytotoxicity against B-cell malignancies. Currently, autologous T cells are conventionally used to manufacture CAR T cells. Low quality or insufficient quantity of autologous T cells may lead to failure of CAR T preparations. Moreover, CAR T preparation usually takes 1–2 weeks, which is too long for patients with rapid disease progression to successfully infuse CAR T cells. Thus, the development of a ready-to-use CAR immunotherapy strategy is needed. NK-92, a natural killer (NK) cell line derived from an NK lymphoma patient, has been gradually applied as a CAR-modified effector cell. To avoid the potential development of secondary NK lymphoma in patients, large doses of radiation are used to treat NK-92 cells before clinical application, which ensures the safety but reduces the cytotoxicity of NK-92 cells. Therefore, it is crucial to explore a suitable radiation dose that ensures short life span and good cytotoxicity of CAR NK-92 cells. Methods NK-92MI, a modified IL-2-independent NK-92 cell line, was used to establish an anti-CD19 CAR NK. The suitable radiation dose of CAR NK was then explored in vitro and validated in vivo, and the specific cytotoxicity of irradiated and unirradiated CAR NK against CD19+ malignant cells was assessed. Results CAR NK exhibited specific cytotoxicity against CD19+ malignant cells. Irradiation ensured a short life span of CAR NK in vitro and in vivo. Encouragingly, irradiated CAR NK displayed an anti-CD19+ malignancy capacity similar to that of unirradiated CAR NK. Conclusions Five Gy is a suitable radiation dose to ensure the safety and effectiveness of CD19 CAR NK-92MI cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI